glp-1 gastroparesis treatment Your guide to side effects New warnings for gastroparesis, severe

Issue 42 of The Altascientist explores GLP-1 receptor agonist drug development, covering preclinical models, bioanalytical assays, clinical study design, and manufacturing

GLP-1 is the hormone our body makes to help reduce hunger and cravings after and in-between meals

Block fat accumulation pathways

Every single-serve Counter meal is engineered to deliver 30g of protein

The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases.

These observations suggest that administration of metformin before meals may optimise its effect in improving postprandial glycaemic control